NEW YORK (GenomeWeb News) - Ensemble Discovery said today it has struck a collaboration with Roche to develop a test that may be used to analyze combinations of specific receptors that may be used to help select cancer patients that are most likely to respond to particular therapies.
 
Under the agreement, the companies will use Ensemble’s DNA Programmed Chemistry technology to study combinations of epidermal growth factor receptors that are found in some cancer tissues.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.